LifeTech Scientific Corporation (HKG:1302)
Hong Kong · Delayed Price · Currency is HKD
1.950
-0.050 (-2.50%)
May 11, 2026, 4:08 PM HKT
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Peripheral Vascular Diseases Business | 844.63M | 751.11M | 707.11M | 644.34M | 548.53M | | | | | |
Peripheral Vascular Diseases Business Growth | 12.45% | 6.22% | 9.74% | 17.47% | 27.40% | | | | | |
Cardiac Pacing and Electrophysiology Business | 13.48M | 25.01M | 64.40M | 58.39M | 45.74M | | | | | |
Cardiac Pacing and Electrophysiology Business Growth | -46.12% | -61.17% | 10.29% | 27.65% | 76.16% | | | | | |
Structural Heart Diseases Business | 511.68M | 527.58M | 495.67M | 394.57M | 331.06M | | | | | |
Structural Heart Diseases Business Growth | -3.01% | 6.44% | 25.62% | 19.19% | 11.43% | | | | | |
| 1.37B | 1.30B | 1.27B | 1.10B | 925.33M | | | | | |
| 5.07% | 2.88% | 15.48% | 18.59% | 44.07% | | | | | |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 973.35M | 957.11M | 992.13M | 895.05M | 774.04M | | | | | |
| 1.70% | -3.53% | 10.85% | 15.63% | 43.62% | | | | | |
| 165.86M | 131.75M | 111.09M | 72.66M | 68.26M | | | | | |
| 25.88% | 18.60% | 52.88% | 6.45% | 18.34% | | | | | |
Asia (Excluding Mainland China and India) | 105.40M | 98.50M | 67.42M | 50.79M | 31.83M | | | | | |
Asia (Excluding Mainland China and India) Growth | 7.00% | 46.10% | 32.75% | 59.57% | 85.86% | | | | | |
| 57.32M | 53.57M | 46.40M | 34.69M | 20.23M | | | | | |
| 7.00% | 15.44% | 33.76% | 71.47% | 82.77% | | | | | |
| 39.74M | 36.07M | 33.53M | 29.95M | 21.14M | | | | | |
| 10.20% | 7.55% | 11.96% | 41.68% | 57.79% | | | | | |
| 22.87M | 18.93M | 11.27M | 8.55M | 7.15M | | | | | |
| 20.82% | 67.93% | 31.92% | 19.52% | 126.91% | | | | | |
| 5.24M | 7.78M | 5.33M | 5.62M | 2.69M | | | | | |
| -32.58% | 45.98% | -5.18% | 108.89% | 190.70% | | | | | |
| 1.37B | 1.30B | 1.27B | 1.10B | 925.33M | | | | | |
| 5.07% | 2.88% | 15.48% | 18.59% | 44.07% | | | | | |
Source: S&P Global Market Intelligence.